news videos images websites

Eli Lilly and Company Company News

Tue, 01 Nov 2016 07:28:23 GMT
Summary of Analyst's Beliefs: Eli Lilly and Company (NYSE:LLY)  -  Is stories
10/31/2016, Eli Lilly and Company (NYSE:LLY) stock dropped -0.93% or -0.69 points. After the session opened at $74.63, the stock's price hit the top of $ 74.74 while it touched a low of $ 73.80. Total 3.56 million shares changed on hands and it kept ...
Tue, 01 Nov 2016 07:09:15 GMT
Kleinwort Benson Investors Dublin Ltd Acquires New Position in Eli Lilly and Co. (LLY)  -  DailyQuint
Kleinwort Benson Investors Dublin Ltd purchased a new stake in Eli Lilly and Co. (NYSE:LLY) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 580,035 shares of the ...
Tue, 01 Nov 2016 00:57:43 GMT
Brokers Issue Forecasts for Eli Lilly and Co.'s FY2017 Earnings (LLY)  -  Cosumnes Connection (subscription)
According to a research note published on Nov 13, 2015, analysts at BMO Capital Markets have upped their rating on the company stock from Market Perform to Outperform. Eli Lilly and Company Drug Manufacturers - Major holds an EPS of 2.32 that ...
Tue, 01 Nov 2016 00:55:54 GMT
Hudson Canyon Investment Counselors Lowers stake in Eli Lilly and Co (LLY)  -  TheFounders Daily
Eli Lilly and Co (LLY) : Hudson Canyon Investment Counselors reduced its stake in Eli Lilly and Co by 18.54% during the most recent quarter end. The investment management company now holds a total of 16,825 shares of Eli Lilly and Co which is valued at ...
Tue, 01 Nov 2016 00:01:35 GMT
Today's Top Gainers in the Market Eli Lilly and Company (NYSE:LLY) from Healthcare  -  The Daily Leicester
Today's top gainers include the company Eli Lilly and Company (NYSE:LLY) which is in the industry Drug Manufacturers – Major, gaining -2.14% today. In the last week its performance is -4.75%, and -9.83% for the past quarter. Currently, Eli Lilly and ...
Mon, 31 Oct 2016 20:04:44 GMT

Amgen, Gilead, Eli Lilly Eat Into AbbVie's Humira Sales: Analyst  -  Investor's Business Daily
Eli Lilly (LLY), Pfizer (PFE) and Gilead Sciences (GILD) are chipping away at AbbVie's (ABBV) Humira sales, Credit Suisse analyst Vamil Divan said Monday after AbbVie missed Q3 expectations Friday, primarily on declining Humira sales. Divan downgraded ...
Mon, 31 Oct 2016 17:21:15 GMT

Notable 13F Reporting: Transamerica Financial Advisors INC Has Lowered Holding in Lilly Eli & Co (LLY) by $3.28 ...  -  Chester News
Transamerica Financial Advisors Inc decreased its stake in Lilly Eli & Co (LLY) by 99.58% based on its latest 2016Q2 regulatory filing with the SEC. Transamerica Financial Advisors Inc sold 41,476 shares as the company's stock rose 7.26% with the market.
Mon, 31 Oct 2016 16:56:46 GMT

Eli Lilly and's (LLY) "Buy" Rating Reaffirmed at Jefferies Group  -  The Cerbat Gem
Eli Lilly and Co. logo Jefferies Group reiterated their buy rating on shares of Eli Lilly and Co. (NYSE:LLY) in a report published on Friday morning. They currently have a $100.00 price objective on the stock, down from their previous price objective ...
Mon, 31 Oct 2016 15:52:06 GMT

Eli Lilly and's (LLY) "Buy" Rating Reiterated at Goldman Sachs Group Inc.  -  Community Financial News
Eli Lilly and Co. logo Goldman Sachs Group Inc. reaffirmed their buy rating on shares of Eli Lilly and Co. (NYSE:LLY) in a report released on Wednesday. They currently have a $95.00 price target on the stock. LLY has been the topic of a number of other ...
Mon, 31 Oct 2016 15:42:35 GMT
Featured Stock to See: Eli Lilly and Company (NYSE:LLY)  -  FactsReporter
The Stock had a 1.67 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 1.77 and 1.92 respectively. Eli Lilly and Company on 9/30/2016 reported its EPS as $0.88 with the analysts ...